# Oramed (ORMP) — Earnings

ORMP · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ormp/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q1 2025 |
| Period end | Mar 31, 2025 |
| EPS actual | −$0.19 |
| EPS estimate | −$0.01 |
| EPS surprise | −1800.00% |
| Revenue surprise | +0.00% |
| Revenue | $2.0M |
| Revenue estimate | $0.00 |
| Reported | May 15, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1176309/000121390025044193/ea0241687-10q_oramed.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q1 2025 | May 15, 2025 | −$0.01 | −$0.19 | -1800.00% | — | $2.0M |
| Q4 2024 | Mar 27, 2025 | −$0.02 | −$0.25 | -1150.00% | — | — |
| Q3 2024 | Nov 7, 2024 | $0.01 | −$0.48 | -9700.00% | — | — |
| Q2 2024 | Aug 14, 2024 | $0.01 | $0.22 | 2100.00% | $250,000.00 | — |
| Q1 2024 | May 9, 2024 | $0.04 | $0.04 | 0.00% | — | — |
| Q4 2023 | Mar 6, 2024 | −$0.12 | $0.33 | 370.83% | — | — |
| Q3 2023 | Nov 9, 2023 | −$0.09 | −$0.08 | 5.88% | $700,000.00 | — |
| Q1 2023 | May 11, 2023 | −$0.08 | −$0.08 | 0.00% | $688,667.00 | $700,000.00 |
| Q3 2022 | Nov 10, 2022 | −$0.25 | −$0.18 | 28.94% | $696,833.00 | $682,000.00 |
| Q2 2022 | Aug 10, 2022 | −$0.24 | −$0.27 | -12.17% | $700,000.00 | $674,000.00 |
| Q1 2022 | May 12, 2022 | −$0.24 | −$0.28 | -14.58% | $692,500.00 | $700,000.00 |
| Q3 2021 | Jul 14, 2021 | −$0.20 | −$0.17 | 16.05% | $970,250.00 | $700,000.00 |
| Q1 2021 | Jan 14, 2021 | −$0.18 | −$0.23 | -26.03% | $670,333.00 | $700,000.00 |
| Q4 2020 | Nov 24, 2020 | −$0.21 | −$0.13 | 40.48% | $1.7M | $681,000.00 |
| Q3 2020 | Jul 7, 2020 | −$0.19 | −$0.10 | 46.67% | $1.0M | $700,000.00 |

## Frequently Asked Questions

### When did Oramed (ORMP) last report earnings?

Oramed last reported on May 15, 2025, covering fiscal Q1 2025.

### Did ORMP beat earnings estimates?

No. Oramed reported EPS of −$0.19 for Q1 2025 against a −$0.01 estimate — a 1800.00% miss.

### How much revenue did ORMP report last quarter?

Oramed reported $2.0M in revenue for Q1 2025.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).